The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task Force

被引：24

作者：

Garbe, C. ^{[1
]}

Peris, K. ^{[2
,3
]}

Soura, E. ^{[4
]}

Forsea, A. M. ^{[5
]}

Hauschild, A. ^{[6
]}

Arenbergerova, M. ^{[7
]}

Bylaite, M. ^{[8
]}

del Marmol, V. ^{[9
]}

Bataille, V. ^{[10
,11
]}

Samimi, M. ^{[12
]}

Gandini, S. ^{[13
]}

Saiag, P. ^{[14
,15
]}

Eigentler, T. K. ^{[16
]}

Lallas, A. ^{[17
]}

Zalaudek, I. ^{[18
]}

Lebbe, C. ^{[19
]}

Grob, J. -J. ^{[20
]}

Hoeller, C. ^{[21
]}

Robert, C. ^{[22
,23
]}

Dreno, B. ^{[24
]}

Arenberger, P. ^{[7
]}

Kandolf-Sekulovic, L. ^{[25
]}

Kaufmann, R. ^{[26
]}

Malvehy, J. ^{[27
,28
]}

Puig, S. ^{[27
,28
]}

Leiter, U. ^{[1
]}

Ribero, S. ^{[29
]}

Papadavid, E. ^{[30
]}

Quaglino, P. ^{[29
]}

Bagot, M. ^{[19
]}

John, S. M. ^{[31
]}

Richard, M. -A ^{[20
]}

Trakatelli, M. ^{[32
]}

Salavastru, C. ^{[33
]}

Borradori, L. ^{[34
]}

Marinovic, B. ^{[35
]}

Enk, A. ^{[36
]}

Pincelli, C. ^{[37
]}

Ioannides, D. ^{[17
]}

Paul, C. ^{[38
]}

Stratigos, A. J. ^{[4
]}

机构：

[1] Eberhard Karls Univ Tuebingen, Dept Dermatol, Ctr Dermatooncol, Tubingen, Germany

[2] Fdn Policlin Univ A Gemelli IRCCS, Dermatol, Rome, Italy

[3] Univ Cattolica Sacro Cuore, Dermatol, Rome, Italy

[4] Natl & Kapodestrian Univ Athens, Andreas Sygros Hosp, Dept Dermatol Venereol 1, Athens, Greece

[5] Carol Davila Univ Med & Pharm, Univ Hosp Elias, Dept Oncol Dermatol, Bucharest, Romania

[6] Univ Kiel, Dept Dermatol, Kiel, Germany

[7] Charles Univ Prague, Univ Hosp Kralovske Vinohrady, Fac Med 3, Dept Dermatovenereol, Prague, Czech Republic

[8] Vilnius Univ, Ctr Dermatovenereol, Clin Infect Dis & Dermatovenereol, Fac Med, Vilnius, Lithuania

[9] Univ Libre Bruxelles, Erasme Hosp, Dermatol Dept, Brussels, Belgium

[10] West Herts NHS Trust, Dermatol Dept, London, England

[11] Kings Coll London, Twin Res & Genet Epidemiol Dept, London, England

[12] Univ Hosp Tours, Dept Dermatol, Tours, France

[13] European Inst Oncol IRCCS, Dept Expt Oncol, Mol & Pharmacoepidemiol Unit, IEO, Milan, Italy

[14] Univ Paris Saclay, Ambroise Pare Hosp, APHP, Dept Gen & Oncol Dermatol, Boulogne, France

[15] Univ Paris Saclay, Biomarkers Cancerol & Hematooncol, UVSQ, EA 4340, Boulogne, France

[16] Univ Hosp Tubingen, Dept Dermatol, Tubingen, Germany

[17] Aristotle Univ Thessaloniki, Med Sch, Dermatol Dept 1, Thessaloniki, Greece

[18] Univ Trieste, Dept Dermatol, Trieste, Italy

[19] St Louis Hosp, AP HP, Dept Dermatol, Paris, France

[20] Aix Marseille Univ, Timone Hosp, Marseille, France

[21] Med Univ Vienna, Dept Dermatol, Vienna, Austria

[22] Gustave Roussy Canc Campus, Dept Canc Med, Villejuif, France

[23] Paris Saclay Univ, Le Kremlin Bicetre, France

[24] Univ Nantes, CHU Nantes, Dept Dermatolocancerol, CRCINA,CIC 1413, Nantes, France

[25] Univ Def, Mil Med Acad, Dept Dermatol, Fac Med, Belgrade, Serbia

[26] Univ Hosp Frankfurt, Dept Dermatol Venerol & Allergol, Frankfurt, Germany

[27] Univ Barcelona, Hosp Clin Barcelona, Dermatol Dept, Barcelona, Spain

[28] ISCIII, Biomed Res Networking Ctr Rarae Dis CIBERER, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain

[29] Univ Turin, Dept Med Sci, Dermatol Clin, Turin, Italy

[30] Natl & Kapodistrian Univ Athens, ATTIKON Hosp, Dept Dermatol Venereol 2, Athens, Greece

[31] Univ Osnabrueck, Dept Dermatol, Environm Med, Hlth Theory, Osnabruck, Germany

[32] Aristotle Univ Thessaloniki, Papageorgiou Hosp, Dept Dermatol Venerol 2, Thessaloniki, Greece

[33] Colentina Clin Hosp, Pediat Dermatol Discipline, Dermatooncol Res Facil, Bucharest, Romania

[34] Univ Hosp Bern, Dept Dermatol, Inselspital, Bern, Switzerland

[35] Univ Zagreb, Univ Hosp Ctr Zagreb, Dept Dermatol & Venereol, Sch Med, Zagreb, Croatia

[36] Univ Hosp Heidelberg, Dept Dermatol, Heidelberg, Germany

[37] Univ Modena & Reggio Emilia, DermoLab, Dermatol, Modena, Italy

[38] Toulouse Univ, Dept Dermatol, Toulouse, France

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2020年 / 34卷 / 10期

关键词：

MYCOSIS FUNGOIDES/SEZARY SYNDROME; CLINICAL-PRACTICE GUIDELINES; SQUAMOUS-CELL CARCINOMA; SKIN-CANCER PREVENTION; RISK-FACTORS; INTERDISCIPLINARY GUIDELINE; FOLLOW-UP; MELANOCYTIC NEVI; CTLA-4; BLOCKADE; MELANOMA;

D O I：

10.1111/jdv.16849

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Background The incidence of skin cancers has been increasing steadily over the last decades. Although there have been significant breakthroughs in the management of skin cancers with the introduction of novel diagnostic tools and innovative therapies, skin cancer mortality, morbidity and costs heavily burden the society. Objective Members of the European Association of Dermato-Oncology, European Academy of Dermatology and Venereology, International Dermoscopy Society, European Dermatology Forum, European Board of Dermatovenereology of the European Union of Medical Specialists and EORTC Cutaneous Lymphoma Task Force have joined this effort to emphasize the fundamental role that the specialist in Dermatology-Venereology has in the diagnosis and management of different types of skin cancer. We review the role of dermatologists in the prevention, diagnosis, treatment and follow-up of patients with melanoma, non-melanoma skin cancers and cutaneous lymphomas, and discuss approaches to optimize their involvement in effectively addressing the current needs and priorities of dermato-oncology. Discussion Dermatologists play a crucial role in virtually all aspects of skin cancer management including the implementation of primary and secondary prevention, the formation of standardized pathways of care for patients, the establishment of specialized skin cancer treatment centres, the coordination of an efficient multidisciplinary team and the setting up of specific follow-up plans for patients. Conclusion Skin cancers represent an important health issue for modern societies. The role of dermatologists is central to improving patient care and outcomes. In view of the emerging diagnostic methods and treatments for early and advanced skin cancer, and considering the increasingly diverse skills, knowledge and expertise needed for managing this heterogeneous group of diseases, dermato-oncology should be considered as a specific subspecialty of Dermatology-Venereology.

引用

页码：2183 / 2197

页数：15

共 108 条

[1] Association of Increased Dermatologist Density With Lower Melanoma Mortality [J].

Aneja, Savina ;

Aneja, Sanjay ;

Bordeaux, Jeremy S. .

ARCHIVES OF DERMATOLOGY, 2012, 148 (02) :174-178

[2]

[Anonymous], 2012, BMJ BRIT MED J, DOI DOI 10.1136/BMJ.E4757

[3]

[Anonymous], 2020, BMJ BRIT MED J, DOI DOI 10.1136/BMJ.M127

[4] HOW MUCH MELANOMA IS CAUSED BY SUN EXPOSURE [J].

ARMSTRONG, BK ;

KRICKER, A .

MELANOMA RESEARCH, 1993, 3 (06) :395-401

[5] The COVID-19 crisis: A unique opportunity to expand dermatology to underserved populations [J].

Ashrafzadeh, Sepideh ;

Nambudiri, Vinod E. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) :E83-E84

[6] Perception and image of dermatology in the German general population 2002-2014 [J].

Augustin, M. ;

Eissing, L. ;

Elsner, P. ;

Stroemer, K. ;

Schaefer, I. ;

Enk, A. ;

Reusch, M. ;

Kaufmann, R. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (12) :2124-2130

[7]

Barbaric J, 1990, EUR J CANCER, V2016, P47

[8] Effect of sunscreen and clothing on the number of melanocytic nevi in 1,812 German children attending day care [J].

Bauer, A ;

Büttner, P ;

Wiecker, TS ;

Luther, H ;

Garbe, C .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (07) :620-627

[9] Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence [J].

Bordoni, Andrea ;

Leoni-Parvex, Sandra ;

Peverelli, Simona ;

Mazzola, Paola ;

Mazzucchelli, Luca ;

Spitale, Alessandra .

MELANOMA RESEARCH, 2013, 23 (05) :402-407

[10] Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases [J].

Bradford, Porcia T. ;

Devesa, Susan S. ;

Anderson, William F. ;

Toro, Jorge R. .

BLOOD, 2009, 113 (21) :5064-5073

← 1 2 3 4 5 6 7 8 9 10 →